[1] COLLABORATORS GBDF. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2021;2(9):e580-e592.
[2] FENG JN, ZHANG CG, LI BH, et al. Global burden of hip fracture: The Global Burden of Disease Study. Osteoporos Int. 2024;35(1):41-52.
[3] TAI TW, LIN YH, CHANG CJ, et al. The economic burden of hip fractures in Asia. Osteoporos Sarcopenia. 2021;7(2):45-46.
[4] BAJI P, PATEL R, JUDGE A, et al. Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort study. Lancet Healthy Longev. 2023;4(8):e386-e398.
[5] ADEYEMI A, DELHOUGNE G. Incidence and Economic Burden of Intertrochanteric Fracture: A Medicare Claims Database Analysis. JB JS Open Access. 2019;4(1):e0045.
[6] 张强, 李大伟, 刘凝昊, 等. 股骨转子间骨折行髓内钉治疗后营养风险预测模型的建立[J]. 中国组织工程研究,2024,28(21):3380-3384.
[7] 夏冰, 张永华, 刘振鹏, 等. 老年股骨粗隆间骨折的组合微创半髋置换术[J]. 中国矫形外科杂志,2022,30(14):1303-1306.
[8] GUZON-ILLESCAS O, PEREZ FERNANDEZ E, CRESPI VILLARIAS N, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019;14(1):203.
[9] HARVEY LA, PAYNE NL, TAN A, et al. Variation in mortality following hip fracture across the Asia Pacific region: Systematic review and proportional meta-analysis. Arch Gerontol Geriatr. 2024;126:105519.
[10] SING CW, LIN TC, BARTHOLOMEW S, et al. Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality. J Bone Miner Res. 2023;38(8):1064-1075.
[11] MOHSENI V, FAHIMFAR N, ANSARIFAR A, et al. Mortality and re-fracture rates in low trauma hip fracture. BMC Geriatr. 2024;24(1):381.
[12] HELYNEN N, RANTANEN L, LEHENKARI P, et al. Predisposing factors for a second fragile hip fracture in a population of 1130 patients with hip fractures, treated at Oulu University Hospital in 2013-2016: a retrospective study. Arch Orthop Trauma Surg. 2023;143(5):2261-2271.
[13] VOCHTELOO AJ, BORGER VAN DER BURG BL, ROLING MA, et al. Contralateral hip fractures and other osteoporosis-related fractures in hip fracture patients: incidence and risk factors. An observational cohort study of 1,229 patients. Arch Orthop Trauma Surg. 2012;132(8): 1191-1197.
[14] VAN DER STEENHOVEN TJ, STAFFHORST B, VAN DE VELDE SK, et al. Complications and institutionalization are almost doubled after second hip fracture surgery in the elderly patient. J Orthop Trauma. 2015;29(3):e103-108.
[15] TREVISAN C, BEDOGNI M, PAVAN S, et al. The impact of second hip fracture on rehospitalization and mortality in older adults. Arch Gerontol Geriatr. 2020;90:104175.
[16] LLOPIS-CARDONA F, ARMERO C, HURTADO I, et al. Incidence of Subsequent Hip Fracture and Mortality in Elderly Patients: A Multistate Population-Based Cohort Study in Eastern Spain. J Bone Miner Res. 2022;37(6):1200-1208.
[17] CHEN M, LI Y, YANG Y, et al. Analysis of the risk factors for contralateral refracture after hip fracture surgery in elderly individuals: a retrospective study. J Orthop Surg Res. 2024;19(1):681.
[18] ZHAO L, TIAN S, SHA W, et al. Analysis of the clinical characteristics and risk factors associated with contralateral hip fracture after initial hip fracture in elderly patients: a retrospective cohort study. Sci Rep. 2024;14(1):14292.
[19] LIANG J, ZHANG J, LOU Z, et al. Development and validation of a predictive nomogram for subsequent contralateral hip fracture in elderly patients within 2 years after hip fracture surgery. Front Med (Lausanne). 2023;10:1263930.
[20] RATNASAMY PP, RUDISILL KE, OGHENESUME OP, et al. Risk of Contralateral Hip Fracture Following Initial Hip Fracture Among Geriatric Fragility Fracture Patients. J Am Acad Orthop Surg Glob Res Rev. 2023;7(7):e23.00001.
[21] 刘勇, 丁生权, 陈国川, 等. 老年髋部骨折术后对侧再骨折的独立风险因素分析 [J]. 中国骨与关节杂志,2021,10(9):649-654.
[22] SONG M, WANG Y, JIANG Y, et al. Risk factors for subsequent fractures in hip fracture patients: a nested case-control study. J Orthop Surg Res. 2024;19(1):348.
[23] JIANG Y, ZHU Y, ZHANG B, et al. Characteristics of subsequent contralateral proximal femoral fracture: more convenient access is needed to treat osteoporosis. J Orthop Surg Res. 2023;18(1):126.
[24] 严广斌. Singh指数[J]. 中华关节外科杂志(电子版),2016,10(2): 236.
[25] CHAU NVV, NGOC NM, NGUYET LA, et al. An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam. E Clin Med. 2021;41:101143.
[26] ZHU Y, CHEN W, SUN T, et al. Epidemiological characteristics and outcome in elderly patients sustaining non-simultaneous bilateral hip fracture: a systematic review and meta-analysis. Geriatr Gerontol Int. 2015;15(1):11-18.
[27] YAMANASHI A, YAMAZAKI K, KANAMORI M, et al. Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos Int. 2005;16(10):1239-1246.
[28] FUKUSHIMA T, SUDO A, UCHIDA A. Bilateral hip fractures. J Orthop Sci. 2006;11(5):435-438.
[29] OMSLAND TK, EMAUS N, TELL GS, et al. Ten-year risk of second hip fracture. A NOREPOS study. Bone. 2013;52(1):493-497.
[30] GIBSON-SMITH D, KLOP C, ELDERS PJ, et al. The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporos Int. 2014;25(11):2555-2563.
[31] CHEN M, DU Y, TANG W, et al. Risk factors of mortality and second fracture after elderly hip fracture surgery in Shanghai, China. J Bone Miner Metab. 2022;40(6):951-959.
[32] CHUANG PY, SHEN SH, YANG TY, et al. Non-steroidal anti-inflammatory drugs and the risk of a second hip fracture: a propensity-score matching study. BMC Musculoskelet Disord. 2016;17:201.
[33] ZIDROU C, VASILIADIS AV, RIZOU S, et al. Second hip fracture in older adults: incidence and risk factors. Eur J Orthop Surg Traumatol. 2023; 33(5):1599-1606.
[34] HARVEY L, TOSON B, MITCHELL R, et al. Incidence, timing and impact of comorbidity on second hip fracture: a population-based study. ANZ J Surg. 2018;88(6):577-581.
[35] FIGUEROA CA, ROSEN CJ. Parkinson’s disease and osteoporosis: basic and clinical implications. Expert Rev Endocrinol Metab. 2020;15(3): 185-193.
[36] TAN L, WANG Y, ZHOU L, et al. Parkinson’s disease and risk of fracture: a meta-analysis of prospective cohort studies. PLoS One. 2014;9(4): e94379.
[37] GIBSON LL, WEINTRAUB D, LEMMEN R, et al. Risk of Dementia in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Mov Disord. 2024;39(10):1697-1709.
[38] LARRAINZAR-GARIJO R, DIEZ-PEREZ A, FERNANDEZ-TORMOS E, et al. Risk factors for a second nonsimultaneous hip fracture in a prospective cohort study. Arch Orthop Trauma Surg. 2022;142(10):2611-2617.
[39] HJELHOLT TJ, JOHNSEN SP, BRYNNINGSEN PK, et al. Impact of Stroke History on the Risk of Recurrent Hip Fracture or Major Osteoporotic Fractures among Patients with Incident Hip Fracture: A Nationwide Cohort Study. J Bone Miner Res. 2023;38(2):278-287.
[40] WANG L, YIN L, YANG M, et al. Muscle density is an independent risk factor of second hip fracture: a prospective cohort study. J Cachexia Sarcopenia Muscle. 2022;13(3):1927-1937.
[41] WANG L, YANG M, GE Y, et al. Muscle size and density are independently associated with death after hip fracture: A prospective cohort study. J Cachexia Sarcopenia Muscle. 2023;14(4):1824-1835.
[42] 中国加速康复外科专家组. 中国加速康复外科围术期管理专家共识(2016版)[J]. 中华消化外科杂志,2016,15(6):527-533. |